{"id":"da-5204","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"DA-5204 appears to be a cell-based or regenerative therapy developed for tissue repair applications. The exact molecular mechanism is not widely published in public databases, but it is being investigated in Phase 3 trials, suggesting it has demonstrated preliminary efficacy in preclinical and Phase 2 studies.","oneSentence":"DA-5204 is a regenerative medicine therapy designed to promote tissue repair and regeneration through stem cell or cellular mechanisms.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:08:30.135Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Spinal cord injury (most likely based on Seoul National University Hospital focus)"}]},"trialDetails":[{"nctId":"NCT03998969","phase":"PHASE3","title":"Efficacy of DA-5204 on Gastroesophageal Reflux Disease","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2016-06-01","conditions":"Esophageal Disease","enrollment":70},{"nctId":"NCT02282670","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of DA-5204","status":"UNKNOWN","sponsor":"Dong-A ST Co., Ltd.","startDate":"2014-04","conditions":"Acute Gastritis, Chronic Gastritis","enrollment":434}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Stillen 2X®"],"phase":"phase_3","status":"active","brandName":"DA-5204","genericName":"DA-5204","companyName":"Seoul National University Hospital","companyId":"seoul-national-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"DA-5204 is a regenerative medicine therapy designed to promote tissue repair and regeneration through stem cell or cellular mechanisms. Used for Spinal cord injury (most likely based on Seoul National University Hospital focus).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}